Baytril^® (enrofloxacin) Antibacterial Tablets

For Dogs and Cats

CAUTION:

• Federal (U.S.A.) Law restricts this drug to use by or on the order of a licensed veterinarian.
• Federal law prohibits the extra label use of this drug in food-producing animals.

WARNINGS:

• For use in animals only.
• In rare instances, use of this product in cats has been associated with Retinal Toxicity. Do not exceed 5 mg/kg of body weight per day in cats.
• Safety in breeding or pregnant cats has not been established.
  
• Keep out of reach of children
• Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult physician if irritation persists following ocular or dermal exposure. Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight.

PRECAUTIONS:

• Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures.
• Quinolone-class drugs have been associated with cartilage erosions in weight-bearing joints and other forms of arthropathy in immature animals of various species.
• The use of fluoroquinolones in cats has been reported to adversely affect the retina. Such products should be used with caution in cats.

Baytril^® (enrofloxacin) Antibacterial Injectable Solution 2.27%

For Dogs Only

CAUTION:

• Federal (U.S.A.) Law restricts this drug to use by or on the order of a licensed veterinarian.
• Federal law prohibits the extra label use of this drug in food-producing animals.

CONTRAINDICATIONS:

• Enrofloxacin is contraindicated in dogs known to be hypersensitive to quinolones.
• The use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age).
• The safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. 

WARNING:

• The use of fluoroquinolones in cats may result in Retinal Toxicity.

PRECAUTIONS:

• Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures.
• Quinolone-class drugs have been associated with cartilage erosions in weight-bearing joints and other forms of arthropathy in immature animals of various species.
• The use of fluoroquinolones in cats has been reported to adversely affect the retina. Such products should be used with caution in cats.

ANIMAL SAFETY SUMMARY:

• Oral treatment of 15 to 28 week old growing puppies with daily dosage rates of 25 mg/kg has induced abnormal carriage of the carpal joint and weakness in the hindquarters.
• Daily doses of 125 mg/kg for up to 11 days induced vomition, inappetence, depression, difficult locomotion and death while adult dogs receiving 50 mg/kg/day for 14 days had clinical signs of vomition and inappetence.

Product Label